Report: MLB, Bosch start discussion about PED cases possibly involving Braun
Milwaukee Brewers' Ryan Braun walks back to the dugout after the 4th inning against the Oakland Athletics on Tuesday, June 4th, 2013 at Miller Park. The MLB is looking to suspend Braun among 20 other players in connections to the Biogenesis Clinic. MARK FELIX / MFELIX@JOURNALSENTINEL.COM Photo: Image by Mark Felix
MILWAUKEE - As the Milwaukee Brewers prepare to take the field Saturday night, Major League Baseball has begun conversation with the man who owned the firm which is connected to the Ryan Braun performance-enhancing drug case.
FOX Sports' Ken Rosenthal made this report Saturday night:
As I just reported on the @mlbonfox pre-game show, baseball has started talking to Anthony Bosch.— Ken Rosenthal (@Ken_Rosenthal) June 8, 2013
He did not say any result has come yet from their discussion.
Braun's name has been found on documents reportedly from the Biogenesis firm, which is being investigated for allegedly providing performance-enhancers to Braun and 20 other MLB players.
ESPN reported Braun and 20 other players could be suspended in connection with Biogenesis.
Rosenthal said on the FOX pregame show that according to the MLB and the MLB Players Association's collective bargaining deal, Commissioner Bud Selig could suspend players even if they have not tested positive for PED's, so long as there is sufficient evidence to establish just cause.